Genstar in $790m research lab deal(3)

San Francisco-based Genstar Capital will acquire clinical research organization PRA International in $790 million deal – the largest the firm has announced to date.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this